Bethyl Laboratories
Rabbit anti-CD25/IL-2R alpha Recombinant Monoclonal Antibody [BLGR013]New
Primary
Catalog #A701-013
TargetCD25/IL-2R alpha
HostRabbit
CloneBLGR013
ReactivityHuman
ApplicationIHC
Image 1 of 1
local_shipping
This item has an estimated lead time of two weeks.
Product Description
The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. The IL2 receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells. [taken from NCBI Entrez Gene (Gene ID: 3559)].
Specifications
Clonality
Recombinant Monoclonal
Clone
BLGR013
Host
Rabbit
Isotype
IgG
Reactivity
Human
Format
Whole IgG
Conjugate Type
Unconjugated
Purity
Purified
Target Identity
TargetCD25/IL-2R alpha
Antigen Species
Human
Gene ID3559
Gene Symbol
IL2RA
Gene Name
interleukin 2 receptor subunit alpha
Uniprot IDP01589
Protein Name
Interleukin-2 receptor subunit alpha
Alternate Names
Product Information
Applications
IHC
Buffer
Tris-buffered Saline with 1% BSA and <0.1% Sodium Azide
Storage Conditions
2 - 8 °C
Physical State
Liquid
Shelf Life
1 year from date of receipt
Country of Origin
USA
Applications
Immunohistochemistry (IHC)1:50 to 1:200
Documents
Product DatasheetPDF · A701-013 · Lot 1 (current lot)Open
Product DatasheetPDF · A701-013 · Lot 1 (current lot)Open
Safety Data SheetPDF · A701-013Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



